Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FH338
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,102
Award facts
- Contract value 100% obligated
- $14,102.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,102.14 to AmerisourceBergen Drug Corp on December 28, 2025, under a firm fixed-price contract mechanism with an ultimate completion date of December 29, 2025. This award was not set-aside and represents a competitive procurement from the prime contractor's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The work will be performed at the contractor's Corporate Office location in Conshohocken, PA.
This delivery order falls within AmerisourceBergen's broader portfolio of pharmaceutical product and medical supply deliveries to federal agencies. Through its DLA Troop Support Medical contract, the company supplies a comprehensive range of medical commodities including brand-name and generic medications, vaccines, specialty pharmaceuticals for conditions such as diabetes and neurological disorders, pain management drugs, antibiotics, and medical devices. The Pharmaceutical Prime Vendor Global Program Generation V contracts represent the DLA's strategic initiative to establish multiple regional awards with different contractors, positioning AmerisourceBergen to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with flexible and comprehensive pharmaceutical supply capabilities.
Quick answers
Who was awarded contract SPE2DU26FH338?
SPE2DU26FH338 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 28, 2025.
How much is contract SPE2DU26FH338 worth?
The government has obligated $14,102 on SPE2DU26FH338.
Is contract SPE2DU26FH338 an order under another contract?
Yes. SPE2DU26FH338 is a delivery order under SPE2DU25D4116, an indefinite delivery contract.
Was contract SPE2DU26FH338 competed?
The extent of competition for SPE2DU26FH338 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award